Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PURE-LC: Probiotics for Long COVID
NCT06643299Phase 2Completed
- Sponsor
- Rush University Medical Center
- Start
- May 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post acute COVID-19 syndrome (2 arms), sponsored by Rush University Medical Center. Primary endpoint: Difference in Long COVID Severity at 8 months. Started May 2025; status: completed.
02
Conditions
post acute COVID-19 syndrome
Beyond the preview
Go deeper on NCT06643299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06643299.